Overcoming Barriers to Access

Our objective is to lower the cost of medicines, vaccines and tests through competition, to ensure patents are not a barrier to access and to push back against harmful trade deals or entrenched industry interests.

14. October 2016.

In lead-up to RCEP, MSF urges countries not to trade away access to medicines

As negotiators for the Regional Comprehensive Economic Partnership (RCEP) trade agreement prepare to meet in Tianjin, China, from 17-21 October, MSF urges the 16 negotiating countries to reject any terms in the deal that will harm access to medicines.
Read more


Access Barriers: The Issues

© Juan Carlos Tomasi

Learn about the major barriers to access to drugs, tests and vaccines that MSF is trying to break down.

» Read more

Featured multimedia

Kala Azar: Still Waiting
Some three decades ago, a mystery disease spread throughout Sudan and what is now South Sudan, decimating communities, sewing fear, and killing scores...

Tags: Sudan, kala azar, visceral leishmaniasis, neglected diseases, R&D

↑ To top